Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical Microbiology and Infection

Published byAbner Robbins Modified over 5 years ago

Similar presentations

Presentation on theme: "Clinical Microbiology and Infection"— Presentation transcript:

1 Clinical Microbiology and Infection
Oral presentations  Clinical Microbiology and Infection  Volume 15, Pages S1-S106 (May 2009) DOI: /j x Copyright © Terms and Conditions

2 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

3 Figure Annual percentage of E. coli isolates susceptible to meropenem, cefepime, piperacillin/tazobactam, tobramycin and ciprofloxacin. Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

4 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

5 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

6 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

7 Fig 1 Effect of active immunisation against SesC on S. epidermidis biofilms 1 and 3 days after catheter implantation. Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

8 Figure CRP/CD11b RATIO in clinical practice. The horizontal line indicates the optimal cut-off point value of 3.1 in detecting Gram-positive sepsis. Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

9 Figure Relative risk of IA use of AMT against largest hospital (hospital C). Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

10 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

11 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

12 ESBL strains and the proportion of CTX-M genes in 2004–2008.
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

13 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

14 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

15 Figure 1 Effect of reserpine on the mutation frequency of pneumococcal isolates with identical MLST sequence type. Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

16 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

17 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

18 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

19 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

20 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

21 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

22 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

23 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

24 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

25 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

26 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

27 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

28 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

29 Clinical Microbiology and Infection 2009 15, S1-S106DOI: (10. 1111/j
Clinical Microbiology and Infection  , S1-S106DOI: ( /j x) Copyright © Terms and Conditions

Download ppt "Clinical Microbiology and Infection"

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages 19-23.

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
Intrapopulation variability in mutator prevalence among urinary tract infection isolates of Escherichia coli  A. Couce, N. Alonso-Rodriguez, C. Costas,

Intrapopulation variability in mutator prevalence among urinary tract infection isolates of Escherichia coli  A. Couce, N. Alonso-Rodriguez, C. Costas,
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,

Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times  F.B. Spencker, L. Staber, T. Lietz,
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 

R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
Approach to diagnosis of infective endocarditis

Approach to diagnosis of infective endocarditis
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 

D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Herpes zoster in non-hospitalized children

Herpes zoster in non-hospitalized children
Necrotizing pneumonia caused by nanC-carrying serotypes is associated with pneumococcal haemolytic uraemic syndrome in children  R.-P. Janapatla, M.-H.

Necrotizing pneumonia caused by nanC-carrying serotypes is associated with pneumococcal haemolytic uraemic syndrome in children  R.-P. Janapatla, M.-H.
F. Danion  Clinical Microbiology and Infection 

F. Danion  Clinical Microbiology and Infection 
K. Diestra, E. Miró, C. Martí, D. Navarro, J. Cuquet, P. Coll, F

K. Diestra, E. Miró, C. Martí, D. Navarro, J. Cuquet, P. Coll, F
Increased conjugation frequencies in clinical Enterococcus faecium strains harbouring the enterococcal surface protein gene esp  B. Lund, H. Billström,

Increased conjugation frequencies in clinical Enterococcus faecium strains harbouring the enterococcal surface protein gene esp  B. Lund, H. Billström,
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 

A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.

Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.
Development of 16S rRNA-based probes for the identification of Gram-positive anaerobic cocci isolated from human clinical specimens  A.C.M. Wildeboer-Veloo,

Development of 16S rRNA-based probes for the identification of Gram-positive anaerobic cocci isolated from human clinical specimens  A.C.M. Wildeboer-Veloo,
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.

Similar presentations

Ads by Google